Related Experiment Videos
Biocompatibility of human collagen type IV intracorneal implants
D Dupont1, P Gravagna, P Albinet
1Laboratoires Biodomi, Saint-Just-Chaleyssin, France.
Cornea
|December 1, 1989
Summary
A novel biomaterial derived from human placental collagen type IV shows excellent biocompatibility as corneal inlays. This new material for refractive keratoplasty demonstrated no adverse reactions in dogs over a two-year study period.
Area of Science:
- Ophthalmology
- Biomaterials Science
- Regenerative Medicine
Background:
- Corneal inlays are used for refractive keratoplasty.
- Biocompatibility of implanted materials is crucial for ocular health.
- Human placental collagen type IV is a potential biomaterial for ocular applications.
Purpose of the Study:
- To develop and evaluate a novel biomaterial from human placental collagen type IV for use in corneal inlays.
- To assess the biocompatibility and safety of these corneal inlays in a preclinical model.
Main Methods:
- Development of corneal inlays using human placental collagen type IV.
- Intracorneal implantation of lenses in eight dogs.
- Two-year postoperative follow-up including clinical observation, endothelial cell assessment, and histological/ultrastructural analysis.
Main Results:
- Corneal inlays remained clear with no inflammatory reactions observed throughout the 2-year follow-up.
- Endothelial cells remained unaltered, and no signs of inflammation, ulceration, or encapsulation were detected histologically.
- No fibroblastic activity was observed at the interface between the inlay and the corneal stroma.
Conclusions:
- Corneal inlays manufactured from human placental collagen type IV exhibit excellent biocompatibility and safety.
- This biomaterial is a promising candidate for refractive keratoplasty applications.
- The study supports the potential of placental collagen-derived materials in ocular surgery.